ÂÜÀòÂÒÂ×

Chris Lehman is an accomplished executive with extensive experience in the biotech and pharmaceutical sectors. Currently serving as Chief Business Officer at NephKey Therapeutics since March 2023 and as Founder and Chief Executive Officer of Collabrity since August 2022, Chris specializes in providing strategic consulting for early-stage therapeutic biotech companies. Previous roles include Chief Financial Officer at Avellino Lab, Chief Financial Officer and Vice President of Finance at Eureka Therapeutics, and Vice President of Financial Strategy at Coherus BioSciences. Chris has a strong track record in financial strategy, fundraising, and operations, contributing to the growth and regulatory readiness of several biotech firms. Educational qualifications include an MBA in Entrepreneurship from the University of California, Berkeley, a BA cum laude in History from Yale University, and a certificate in Advanced Negotiation from Stanford University.